Clinical trials
Hyperhomocysteinemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 1 |
| 2013 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor Research Institute | 1 |
| Georgetown University | 1 |
| National Human Genome Research Institute (NHGRI) | 1 |
| Pamlab, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperhomocysteinemia | 4 |
| Cognitive Dysfunction | 1 |
| Dementia | 1 |
| Kidney Failure, Chronic | 1 |
| Metabolic Diseases | 1 |
| Metabolism, Inborn Errors | 1 |
| Rare Diseases | 1 |
| Respiratory Tract Diseases | 1 |
| Urogenital Diseases | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.